TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
FBRX

Forte Biosciences Inc

Healthcare · Biotechnology

77.00$ +0.0% vs. previous close Closing price · As of: Aug 28, 2026

Statements

Balance Sheet

Forte Biosciences Inc (FBRX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 206 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet FBRX
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
48 39 32 26 18 62 47 108 97 83 67 206
47 38 32 26 18 61 47 108 95 81 65 203
21 12 11 24 16 22 46 106 93 77 58 50
46 37 30 24 16 58 46 106 93 77 58 198
– – – – – – – – 0.5 0.8 0.7 –
7.5 3.7 3.3 9.1 8.6 9.1 9.0 9.2 13 22 25 22
7.5 3.7 3.3 9.1 8.6 9.1 9.0 9.2 13 21 24 20
5.4 1.4 1.7 5.3 5.2 4.9 5.0 5.3 5.5 10.0 13 14
40 35 29 17 9.4 52 38 99 84 61 42 184
-113 -119 -126 -138 -147 -154 -170 -181 -199 -223 -246 -269
1.5 36 1.6 1.8 1.8 6.4 11 12 18 18 18 24

Data as of: August 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?